Target intelligence / Profile preview

Tubulin alpha-1A chain (TUBA1A) (TUBA1A)

Target
TUBA1A
Molecular classification
Enzyme, Other
01

Overview

Tubulin alpha-1A (TUBA1A) is a major structural component of microtubules, which are essential cytoskeletal filaments formed by the polymerization of alpha- and beta-tubulin heterodimers [1, 11]. It is highly expressed in the developing brain and plays a critical role in neuronal migration, axon guidance, and intracellular transport [2, 5, 14]. Mutations in the TUBA1A gene are associated with a spectrum of brain malformations known as tubulinopathies, including lissencephaly and pachygyria, which lead to severe neurological deficits and epilepsy [4, 14, 15]. In clinical practice, tubulin is a primary target for various anti-cancer drugs, such as taxanes and vinca alkaloids, which disrupt microtubule dynamics to induce mitotic arrest and apoptosis [6, 11, 12]. These drugs are generally divided into stabilizing agents, which enhance polymerization, and destabilizing agents, which inhibit it [12]. While most existing drugs target the beta-subunit or the heterodimer interface, TUBA1A remains a key structural element whose regulation and interaction with microtubule-associated proteins are vital for cellular integrity and development [10, 11]. The precise regulation of TUBA1A is essential for the dynamic instability of microtubules, a process required for proper spindle formation during mitosis [11, 12].

Other names
Alpha-tubulin 1Tubulin alpha-1 chainAlpha-tubulin 3Tubulin B-alpha-1LIS3TUBA3B-ALPHA-1Detyrosinated tubulin alpha-1A chain
02

Mechanism of action

Microtubule-targeting agents (MTAs) bind to tubulin to either stabilize (e.g., taxanes) or destabilize (e.g., vinca alkaloids) microtubules, leading to mitotic arrest and apoptosis.

03

Biological functions

Cell cycleCell proliferationCell deathOther
04

Disease associations

CancerOther
05

Safety considerations

Peripheral neuropathyMyelosuppressionDrug resistanceNeurodevelopmental defects
06

Interacting drugs

Paclitaxel

9 more in the full profile.

07

Biomarkers

TUBA1A gene mutationsAcetylated tubulinDetyrosinated tubulin

Beyond the preview

Go deeper on Tubulin alpha-1A chain (TUBA1A) (TUBA1A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tubulin alpha-1A chain (TUBA1A) (TUBA1A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call